P
PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
KOSDAQ:214450
Price:
337 500
KRW
1.66%
Market Closed
Market Cap:
3.5T
KRW
Balance Sheet
Balance Sheet Decomposition
PharmaResearch Co Ltd
PharmaResearch Co Ltd
| Current Assets | 554.5B |
| Cash & Short-Term Investments | 437.4B |
| Receivables | 56.6B |
| Other Current Assets | 60.6B |
| Non-Current Assets | 301.2B |
| Long-Term Investments | 105.7B |
| PP&E | 147.3B |
| Intangibles | 33.4B |
| Other Non-Current Assets | 14.7B |
Balance Sheet
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Currency: KRW
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14 864
|
17 634
|
16 990
|
21 096
|
19 738
|
26 715
|
41 674
|
72 931
|
67 245
|
165 348
|
|
| Cash |
1
|
2
|
6
|
0
|
2
|
5
|
3
|
8
|
67 245
|
165 348
|
|
| Cash Equivalents |
14 863
|
17 632
|
16 984
|
21 096
|
19 736
|
26 710
|
41 672
|
72 923
|
0
|
0
|
|
| Short-Term Investments |
108 181
|
92 349
|
70 622
|
54 301
|
49 292
|
52 552
|
115 123
|
111 412
|
93 053
|
272 003
|
|
| Total Receivables |
5 850
|
10 782
|
18 358
|
17 243
|
20 589
|
26 351
|
30 510
|
36 415
|
36 330
|
56 624
|
|
| Accounts Receivables |
5 725
|
10 689
|
15 310
|
16 028
|
20 225
|
22 890
|
27 928
|
33 202
|
31 812
|
40 500
|
|
| Other Receivables |
125
|
93
|
3 048
|
1 215
|
364
|
3 461
|
2 582
|
3 213
|
4 519
|
16 124
|
|
| Inventory |
4 783
|
5 445
|
5 119
|
12 294
|
13 928
|
20 781
|
17 342
|
24 453
|
50 232
|
57 325
|
|
| Other Current Assets |
538
|
259
|
1 247
|
836
|
926
|
1 005
|
2 142
|
2 134
|
9 604
|
3 241
|
|
| Total Current Assets |
134 214
|
126 468
|
112 335
|
105 769
|
104 473
|
127 404
|
206 792
|
247 345
|
256 465
|
554 542
|
|
| PP&E Net |
20 396
|
20 771
|
27 179
|
66 064
|
73 886
|
94 046
|
109 481
|
117 960
|
123 061
|
147 313
|
|
| PP&E Gross |
20 396
|
20 771
|
27 179
|
66 064
|
73 886
|
94 046
|
109 481
|
117 960
|
123 061
|
147 313
|
|
| Accumulated Depreciation |
2 442
|
3 773
|
5 021
|
7 778
|
12 166
|
15 677
|
21 839
|
26 837
|
34 079
|
42 512
|
|
| Intangible Assets |
1 647
|
2 289
|
2 284
|
31 980
|
29 806
|
26 811
|
26 025
|
24 017
|
20 323
|
19 536
|
|
| Goodwill |
0
|
1 918
|
1 036
|
13 738
|
13 738
|
12 492
|
16 764
|
13 810
|
11 652
|
13 856
|
|
| Note Receivable |
0
|
0
|
0
|
1 000
|
3 624
|
0
|
4 794
|
4 434
|
3 938
|
2 342
|
|
| Long-Term Investments |
12 905
|
27 652
|
45 048
|
37 150
|
40 552
|
54 395
|
58 268
|
59 361
|
112 777
|
105 746
|
|
| Other Long-Term Assets |
144
|
233
|
1 151
|
2 488
|
3 847
|
4 684
|
5 523
|
11 128
|
7 066
|
12 367
|
|
| Other Assets |
0
|
1 918
|
1 036
|
13 738
|
13 738
|
12 492
|
16 764
|
13 810
|
11 652
|
13 856
|
|
| Total Assets |
169 306
N/A
|
179 332
+6%
|
189 034
+5%
|
258 188
+37%
|
269 925
+5%
|
319 831
+18%
|
427 647
+34%
|
478 055
+12%
|
535 281
+12%
|
855 701
+60%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 064
|
2 029
|
1 732
|
4 457
|
5 359
|
1 876
|
2 939
|
3 527
|
2 831
|
11 081
|
|
| Accrued Liabilities |
135
|
179
|
115
|
333
|
492
|
534
|
703
|
860
|
974
|
1 493
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
15 000
|
15 800
|
15 550
|
400
|
250
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
3 019
|
3 507
|
4 581
|
4 961
|
5 024
|
32 606
|
12 231
|
|
| Other Current Liabilities |
5 960
|
3 999
|
5 016
|
7 671
|
9 232
|
13 858
|
23 602
|
29 292
|
29 088
|
57 763
|
|
| Total Current Liabilities |
7 158
|
6 207
|
6 863
|
15 480
|
18 590
|
35 849
|
48 005
|
54 253
|
65 899
|
82 818
|
|
| Long-Term Debt |
5 401
|
0
|
0
|
17 343
|
17 435
|
12 829
|
44 850
|
46 194
|
1 301
|
196 985
|
|
| Deferred Income Tax |
0
|
114
|
0
|
6 061
|
5 404
|
4 746
|
4 514
|
3 741
|
2 794
|
2 156
|
|
| Minority Interest |
0
|
824
|
3 299
|
21 250
|
19 349
|
18 989
|
22 917
|
28 153
|
29 091
|
30 038
|
|
| Other Liabilities |
0
|
546
|
19
|
430
|
73
|
1 996
|
1 919
|
2 211
|
3 092
|
4 301
|
|
| Total Liabilities |
12 559
N/A
|
7 691
-39%
|
10 181
+32%
|
60 565
+495%
|
60 851
+0%
|
74 409
+22%
|
122 205
+64%
|
134 552
+10%
|
102 178
-24%
|
316 299
+210%
|
|
| Equity | |||||||||||
| Common Stock |
4 582
|
4 733
|
4 733
|
4 733
|
4 777
|
4 895
|
5 056
|
5 056
|
5 160
|
5 255
|
|
| Retained Earnings |
34 843
|
46 859
|
56 994
|
69 027
|
82 783
|
112 615
|
154 018
|
190 862
|
260 787
|
343 061
|
|
| Additional Paid In Capital |
116 629
|
121 893
|
121 893
|
122 113
|
124 366
|
131 120
|
150 127
|
155 297
|
172 641
|
194 525
|
|
| Unrealized Security Profit/Loss |
3
|
76
|
166
|
86
|
237
|
104
|
803
|
4 835
|
3 815
|
3 050
|
|
| Treasury Stock |
0
|
2 684
|
4 987
|
267
|
5 260
|
5 260
|
5 260
|
5 260
|
4 638
|
4 638
|
|
| Other Equity |
689
|
763
|
54
|
1 932
|
2 171
|
1 950
|
2 303
|
2 383
|
3 028
|
4 250
|
|
| Total Equity |
156 747
N/A
|
171 641
+10%
|
178 853
+4%
|
197 623
+10%
|
209 075
+6%
|
245 423
+17%
|
305 442
+24%
|
343 503
+12%
|
433 104
+26%
|
539 402
+25%
|
|
| Total Liabilities & Equity |
169 306
N/A
|
179 332
+6%
|
189 034
+5%
|
258 188
+37%
|
269 925
+5%
|
319 831
+18%
|
427 647
+34%
|
478 055
+12%
|
535 281
+12%
|
855 701
+60%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
